This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Board to approve September 2026 quarterly and half-year results
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 4.0 pts less than Nifty Microcap 250 and 3.7 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
The Board will meet on November 4, 2026, to approve unaudited financial results for the quarter and half year ended September 30, 2026. The trading window for designated persons and insiders is closed from October 1 through November 6, 2026.
No results figures or auditor-change details are given. The upcoming results may influence investor sentiment, while insiders cannot trade during the closed window.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹25.87 Cr | ₹18.53 Cr | +39.7% |
| Operating profit | ₹4.19 Cr | ₹3.09 Cr | +35.5% |
| Profit after tax | ₹3.70 Cr | ₹2.86 Cr | +29.4% |
| EBITDA margin | 17.3% | 18.2% | −0.9 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.